Additionally, investigation by Hailemichael et al. on the impact of adjuvant IFA with concomitant anti-CTLA-4 therapy demonstrated sequestration and destruction of anti-CTLA-4 induced effector T cells that were specific for non-vaccine tumor antigens [65]. This evidence concerns the gene CTLA4 and neoplasm.